Important articles

  • If you are ill of ALS, you may want to read this little guide (in French) on home adjustments and possible nutritional supplements.

  • A document calling for creating a TDP-43 gene therapy, which is modeled after gene therapy for spinal muscular atrophy.

  • Certain dewormers for humans, or other products such as dichloroacetic acid, were withdrawn from the market immediately after they were found to have anti-cancer properties. What about Fenbendazole? An article from Nature enlightens us.

  • Unlike many diseases, there are no official ALS biomarkers. This software prototype shows how to use certain biomarkers to maximize chances of survival to ALS.

  • Patients with amyotrophic lateral sclerosis (ALS) experience progressive limb weakness, muscle atrophy, and dysphagia, making them vulnerable to insufficient energy intake. Half of ALS patients suffer from hyper-metabolism. In 2014 Edward J Kasarskis and his colleagues developed equations to estimate energy requirements of ALS patients. Here is the link to calculator using those formulas.

Please, help us continue to provide valuable information: